PMID: 1203214Dec 1, 1975Paper

The effects of stilboestrol and quinestrol upon coagulation and fibrinolysis during the puerperium

British Journal of Obstetrics and Gynaecology
P W HowieC R Prentice

Abstract

Two oestrogens, stilboestrol and quinestrol, were used to inhibit lactation and their effects upon coagulation and fibrinolysis were compared with control patients before delivery, during the puerperium and six weeks after delivery. During the first week of the puerperium, stilboestrol therapy was associated with rises of factors IX and X and quinestrol therapy with rises of factors IX and II. Six weeks after delivery, the clotting factors were similar to the control values in those who had received stilboestrol but factor II was still raised in the quinestrol treated patients. Additionally, a significant rise of factor X in the quinestrol group was noted at this time. Plasma antithrombin levels rose during the first week of the puerperium in all three groups but, six weeks after delivery, they were lower in those who had received oestrogens. Stilboestrol and quinestrol were also associated with a rise of plasminogen and antiplasmin concentration during the first week of the puerperium. Six weeks after delivery, quinestrol treated patients still had raised levels of plasminogen and antiplasmin while the stilboestrol treated patients only had raised levels of antiplasmin. These changes in coagulation and fibrinolysis are similar...Continue Reading

References

Dec 1, 1970·Scandinavian Journal of Clinical and Laboratory Investigation·U AbildgaardO Egeberg
Sep 25, 1965·Lancet·D MacDonald, K O'Driscoll
Aug 5, 1967·Lancet·C Hodge
Aug 5, 1967·Lancet·D G DanielA C Turnbull
Aug 1, 1972·American Journal of Obstetrics and Gynecology·E von KaullaK N von Kaulla
Jul 1, 1973·British Journal of Haematology·P W HowieG P McNicol
Mar 1, 1968·The Journal of Obstetrics and Gynaecology of the British Commonwealth·G M StirratO Grant
Apr 1, 1970·British Journal of Haematology·S M LewisJ V Dacie
Mar 30, 1968·British Medical Journal·D G DanielA C Turnbull
Aug 1, 1968·Scottish Medical Journal·E M Barbour, N K Baruah
Oct 5, 1968·British Medical Journal·T N JeffcoateV R Tindall
Nov 16, 1968·British Medical Journal·D G Millar, E G Robertson
Nov 2, 1968·British Medical Journal·D Brown, M Snell
Feb 15, 1969·British Medical Journal·D Tacchi
Apr 26, 1969·British Medical Journal·K S StewartK J Dennis
Mar 1, 1967·British Journal of Haematology·S M Lewis, J V Dacie
Apr 1, 1959·Obstetrics and Gynecology·J J GOLD, M R COHEN
Feb 1, 1961·Acta Haematologica·K W DENSON
Dec 1, 1961·American Journal of Obstetrics and Gynecology·L L PHILLIPSA L SOUTHAM
Jan 1, 1951·Scandinavian Journal of Clinical and Laboratory Investigation·P A OWREN, K AAS
Oct 29, 1938·British Medical Journal·G L Foss, P Phillips
Jul 2, 1966·British Medical Journal·L Poller, J M Thomson

❮ Previous
Next ❯

Citations

Jan 1, 1980·Pharmacology & Therapeutics·B Westerholm
Sep 1, 1978·British Journal of Obstetrics and Gynaecology·G K OsbourneC R Prentice
May 1, 1979·Postgraduate Medical Journal·P W Howie
Jan 1, 1987·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.